SEBI Reg. Investment Advisor

Download App

Help Center Pricing

Recent:

3B Blackbio Dx inks pact to acquire stake in Coris Holding SRL

3B Blackbio Dx Ltd. | Medical Equipment/Supplies/Accessories | Healthcare | BSE: 532067 | NSE:

28 Jul 2025 Evaluate

3B Blackbio Dx along with its subsidiary -TRUPCR Europe (TPE) - has entered into a definitive agreement with Avacta Group Plc, London to acquire all the shares of Coris Bioconcept SRL’s holding company -- Coris Holding SRL. The shares will be acquired for a total consideration of 2.765 million pound, which includes 2.15 million pound (including net cash & customary working capital adjustments) with an earn-out based on future business performance, of up to 0.615 million pound. The company shall acquire 70% of the total paid-up share capital and TPE shall acquire 30% of the total paid-up share capital by September 10, 2025, and accordingly Coris Bioconcept SRL shall become a subsidiary of the company.

Coris Bioconcept SRL employs a dedicated team of 33 professionals across key functions including R&D, Production, Sales, Marketing, Quality Control, Regulatory Affairs, and Administration. It operates from a new 2,000 square metre facility in Gembloux, Belgium, which houses its R&D and production units, corporate offices, and warehouse. Its product portfolio comprises in vitro diagnostic test kits for AntiMicrobial Resistance (AMR), respiratory, gastroenteric and blood-borne pathogens (bacteria, viruses and parasites), however, it is primarily focused on the antibiotic resistance markers. As part of this portfolio, the it offers a range of rapid lateral flow tests designed to support early and accurate diagnosis at the point of care.

Coris Bioconcept SRL maintains a strong focus on research and development, and a high percentage of expenses is done on R&D, aiming to expand its product portfolio and address emerging diagnostic challenges, particularly in the area of antimicrobial resistance (AMR), with a strong pipeline of AMR products planned to be launched in FY 2026 & 2027, helping to increase Sales & EBITDA in coming years.

3B Blackbio Dx is one of India’s leading Agri-based companies. It manufactures about 50 pesticide products, microfertilizers, biofertilizers and biopesticides.

3B Blackbio Dx Share Price

1197.85 -24.90 (-2.04%)

13-Apr-2026 14:27 View Price Chart

Peers

Company Name	CMP
Lenskart Solutions	547.65
Poly Medicure	1451.10
Laxmi Denta	191.00
Nureca Ltd.	258.40
Hemant Surgical Inds	292.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

PROPRIETARY FRAMEWORK

Portfolio
Architecture >
Stock Picking.

Stop managing a collection of "tips." Access the ABC Framework to build a portfolio that survives cycles and compounds wealth.

Core for Stability

Booster for Alpha

Amplifier for Exponential Wealth

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Access Sapphire ABC Strategy →

Limited Capacity for New Fiduciary Partners

3B Blackbio Dx inks pact to acquire stake in Coris Holding SRL

MoneyWorks4Me Premium

Follow us at

MoneyWorks4Me

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.